Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 14 hours 34 min ago

How to Deal With Layoff-Related Stress

Thu, 04/18/2024 - 02:00
How to Deal With Layoff-Related Stress 4/18/2024

Career Coach: How to Look Professional in Virtual Meetings

Thu, 04/18/2024 - 02:00
Career Coach: How to Look Professional in Virtual Meetings 4/18/2024

5 Top Companies Hiring Oncology Jobs

Thu, 04/18/2024 - 02:00
5 Top Companies Hiring Oncology Jobs 4/18/2024

Lilly Eyes Zepbound Label Expansion After Clearing Phase III Sleep Apnea Study

Wed, 04/17/2024 - 02:00
Lilly Eyes Zepbound Label Expansion After Clearing Phase III Sleep Apnea Study 4/17/2024

Sage Axes Parkinson’s Program for Dalzanemdor After Phase II Flop

Wed, 04/17/2024 - 02:00
Sage Axes Parkinson’s Program for Dalzanemdor After Phase II Flop 4/17/2024

Amylyx Sheds More Light on Relyvrio’s Late-Stage Trial Failure in ALS

Wed, 04/17/2024 - 02:00
Amylyx Sheds More Light on Relyvrio’s Late-Stage Trial Failure in ALS 4/17/2024

Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio?

Wed, 04/17/2024 - 02:00
Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio? 4/17/2024

Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space

Wed, 04/17/2024 - 02:00
Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space 4/17/2024

Top Q1 Series A Investments Highlight VC Rebound in Biopharma

Wed, 04/17/2024 - 02:00
Top Q1 Series A Investments Highlight VC Rebound in Biopharma 4/17/2024

Canaan Secures More Than $100M in New Biopharma Funding, Adds Former Pfizer Executive

Wed, 04/17/2024 - 02:00
Canaan Secures More Than $100M in New Biopharma Funding, Adds Former Pfizer Executive 4/17/2024

Cullinan Targets Autoimmune Market, Nabs $280M in Private Placement

Wed, 04/17/2024 - 02:00
Cullinan Targets Autoimmune Market, Nabs $280M in Private Placement 4/17/2024

GSK Touts Late-Stage Antibiotic Win in Gonorrhea, Long-Term Shingrix Vaccine Data

Wed, 04/17/2024 - 02:00
GSK Touts Late-Stage Antibiotic Win in Gonorrhea, Long-Term Shingrix Vaccine Data 4/17/2024

Arrowhead’s Plozasiran Poised for Dyslipidemia Market, $700M in Sales by 2032: GlobalData

Wed, 04/17/2024 - 02:00
Arrowhead’s Plozasiran Poised for Dyslipidemia Market, $700M in Sales by 2032: GlobalData 4/17/2024

Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages

Wed, 04/17/2024 - 02:00
Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages 4/17/2024

C-Suite Shuffle: Bayer Continues Leadership Shakeup with Hires at Subsidiaries

Wed, 04/17/2024 - 02:00
C-Suite Shuffle: Bayer Continues Leadership Shakeup with Hires at Subsidiaries 4/17/2024

J&J Narrowly Misses Q1 Revenue on Lower-Than-Expected Stelara Sales

Tue, 04/16/2024 - 02:00
J&J Narrowly Misses Q1 Revenue on Lower-Than-Expected Stelara Sales 4/16/2024

Sandoz’s Biosimilar Skyrockets After CVS Removes AbbVie’s Humira from Formularies

Tue, 04/16/2024 - 02:00
Sandoz’s Biosimilar Skyrockets After CVS Removes AbbVie’s Humira from Formularies 4/16/2024

Boehringer Ingelheim Aims to Bring 25 New Products to Market by 2030

Tue, 04/16/2024 - 02:00
Boehringer Ingelheim Aims to Bring 25 New Products to Market by 2030 4/16/2024

Novartis Secures Phase III Fabhalta Win in IgAN as FDA Starts Priority Review

Tue, 04/16/2024 - 02:00
Novartis Secures Phase III Fabhalta Win in IgAN as FDA Starts Priority Review 4/16/2024

Intra-Cellular Touts Phase III Major Depressive Disorder Results for Antipsychotic Drug

Tue, 04/16/2024 - 02:00
Intra-Cellular Touts Phase III Major Depressive Disorder Results for Antipsychotic Drug 4/16/2024